KODAK PHARMACEUTICALS Expands Portfolio and Launches U.S. Online Store
Business Wire•28/10/2026•13:27 ET
0
Key Highlights
- ➤KODAK Normal Saline, 0.9% expands Kodak’s sterile pharmaceutical reagent portfolio
- ➤U.S. online store enables direct ordering of Kodak pharmaceutical-grade buffers and reagents
- ➤Normal Saline is manufactured and aseptically filled in the United States
- ➤Kodak plans additional products and is progressing toward Class II offerings
Expert Statements
Jim Continenza, Executive Chairman and Chief Executive Officer of Kodak
“The launch of KODAK Normal Saline, 0.9% and our new U.S. online store reflect our commitment to making essential pharmaceutical products more accessible to customers”
Jim Continenza, Executive Chairman and Chief Executive Officer of Kodak
“By combining high-quality, domestically produced solutions with a simpler way to purchase them, we are creating a stronger foundation to serve pharmaceutical, biotech, and life science organizations.”
KODAK PHARMACEUTICALS Expands Portfolio and Launches U.S. Online Store
Eastman Kodak Company today announced the expansion of its KODAK PHARMACEUTICALS portfolio with the addition of KODAK® Normal Saline, 0.9%. The company also introduced a new U.S.-based online store designed to simplify purchasing for pharmaceutical, biotech, and life science customers.
Get started
Create a free account to read the full story.